Katja Brose

Title: Katja Brose: Innovator in Modulating Robo-Ligand Interactions

Introduction

Katja Brose is a prominent inventor based in San Francisco, California. She has made significant contributions to the field of biotechnology, particularly in the area of modulating interactions between Robo proteins and their ligands. With a total of four patents to her name, her work has implications for drug development and therapeutic applications.

Latest Patents

One of her latest patents focuses on methods and compositions for identifying agents that modulate the interaction of Robo and a Robo ligand. The disclosed methods involve combining a Robo polypeptide, a Slit polypeptide, and a candidate agent to determine how the agent affects their interaction. This innovative approach is particularly useful in commercial drug screens, as it allows for the identification of modulators that can influence these critical biological interactions.

Career Highlights

Katja Brose is affiliated with the University of California, where she continues her research and development efforts. Her work has garnered attention for its potential to advance understanding in the field of molecular biology and therapeutic interventions.

Collaborations

Some of her notable coworkers include Corey S. Goodman and Thomas Kidd, who have collaborated with her on various research projects. Their combined expertise contributes to the innovative work being conducted in the realm of Robo-ligand interactions.

Conclusion

Katja Brose's contributions to the field of biotechnology through her patents and research are paving the way for advancements in drug development. Her innovative methods for modulating Robo-ligand interactions hold promise for future therapeutic applications.